About aidCURE
aidCURE AG is a German biotechnology company founded by scientists and drug developers to help the large number of patients whose lives are affected by rheumatoid arthritis and other autoimmune diseases. aidCURE is associated with the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Germany.
We are developing a "first-in-class" drug for the treatment of rheumatoid arthritis with unique curative potential. Our therapeutic tolerogenic vaccine represents a paradigm shift in the treatment of rheumatoid arthritis. Our mission is to cure rheumatoid arthritis through the first personalized curative therapeutic and preventive tolerogenic vaccine. Our vision is to improve the lives of sufferers through innovative treatments that address unmet medical needs in the field of autoimmune diseases. Our goal is to obtain market approval for a first-in-class therapeutic vaccine with a unique mode of action and to become the market leader.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Biotechnology, Pharma
